Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $32.88 USD
Change Today -1.00 / -2.95%
Volume 98.9K
FMI On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 07/2/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Steven Kafka Ph.D.

President and Chief Operating Officer, Foundation Medicine, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 3 different industries.

46$849,533
As of Fiscal Year 2014

Background*

Dr. Steven J. Kafka, also known as Steve, Ph.D. serves as the Chief Operating Officer and President of Foundation Medicine, Inc. since March 23, 2015. Dr. Kafka has broad responsibility for business development and operational functions. He served as the Chief Operating Officer of Aileron Therapeutics, Inc since June 2011 until October 2012. He served as the Chief Financial Officer at Aileron Therapeutics Inc., since October 2009 until October 2012. He led Aileron's ...

Read Full Background

Corporate Headquarters*

150 Second Street
Cambridge, Massachusetts 02141

United States

Phone: 617-418-2200
Fax: 617-418-2201

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

PhD
Harvard University
BA
Stanford University

Other Affiliations*

Annual Compensation*

Salary$357,835
Total Annual Compensation$357,835

Stock Options*

Restricted Stock Awards$149,700
Exercisable Options56,436
Exercisable Options Value$915,995
Unexercisable Options131,564
Unexercisable Options Value$2,113,685
Total Value of Options$3,029,680
Total Number of Options188,000

Total Compensation*

Total Annual Cash Compensation$516,455
Total Short Term Compensation$357,835
Other Long Term Compensation$149,700
Total Calculated Compensation$849,533
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
FMI:US $32.88 USD -1.00

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Nachum Shamir Chief Executive Officer and President
Luminex Corporation
$275.0K
Gajus V. Worthington Co-Founder, Chief Executive Officer, President and Director
Fluidigm Corporation
$490.0K
Douglas M. VanOort Executive Chairman and Chief Executive Officer
Neogenomics Inc.
$735.3K
R. Bradley Gray Chief Executive Officer, President and Director
NanoString Technologies, Inc.
$441.8K
Bonnie H. Anderson Co-Founder, Chief Executive Officer, President, Director and Member of Non-Management Equity Award Committee
Veracyte, Inc.
$425.0K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact FOUNDATION MEDICINE INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.